Constantine Tseretopoulos - Templeton Emerging Independent Trustee
| TEI Fund | USD 5.39 0.04 0.74% |
Mr. Constantine D. Tseretopoulos is Independent Trustee of Templeton Emerging Markets Income Fund. He as been Physician, Chief of Staff, owner and operator of the Lyford Cay Hospital director of various nonprofit organizations and formerly, Cardiology Fellow, University of Maryland and Internal Medicine Resident, Greater Baltimore Medical Center .
| Age | 67 |
| Tenure | 26 years |
| Phone | 650-312-3000 |
| Web | https://www.franklintempleton.com/investor/products/mutual-funds/overview?FundID=555 |
Templeton Emerging Management Performance (%)
The company has Return on Asset of 4.18 % which means that on every $100 spent on assets, it made $4.18 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of (25.3) %, meaning that it generated no profit with money invested by stockholders. Templeton Emerging's management efficiency ratios could be used to measure how well Templeton Emerging manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
| Showing other executives | One Year Return | ||
| Susan Pereira | MFS Multimarket Income | 54 | |
| Christopher Bohane | MFS High Income | 51 | |
| Heath McLendon | Stone Harbor Emerging | 87 | |
| Richard Weitzel | MFS High Income | 55 | |
| Brian Langenfeld | MFS High Income | 52 | |
| Martin Wolin | MFS Multimarket Income | 52 | |
| Christopher Bohane | MFS High Yield | 51 | |
| Maureen Goldfarb | MFS High Yield | 65 | |
| Thomas Reynolds | Stone Harbor Emerging | 60 | |
| Jenna Bailey | Western Asset Investment | 41 | |
| Matthew Keener | Aberdeen Australia Ef | 43 | |
| CFA Brown | MFS Multimarket Income | N/A | |
| Benaree Wiley | BNY Mellon High | 73 | |
| Clarence Otis | MFS Government Markets | 64 | |
| Susan Pereira | MFS High Income | 54 | |
| Brian Langenfeld | MFS Multimarket Income | 52 | |
| Brian Langenfeld | MFS High Yield | 52 | |
| Maryanne Roepke | MFS High Yield | 64 | |
| Christopher Bohane | MFS Government Markets | 46 | |
| Sharon Ferrari | Aberdeen Australia Ef | 42 | |
| Maureen Newman | MFS High Yield | N/A | |
Management Performance
| Return On Equity | -25.3 | ||||
| Return On Asset | 4.18 |
Templeton Emerging Leadership Team
Elected by the shareholders, the Templeton Emerging's board of directors comprises two types of representatives: Templeton Emerging inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Templeton. The board's role is to monitor Templeton Emerging's management team and ensure that shareholders' interests are well served. Templeton Emerging's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Templeton Emerging's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Kubilis, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| David Niemiec, Independent Director, Trustee | ||
| Robert Lim, Vice President - AML Compliance | ||
| Matthew Hinkle, Chief Executive Officer - Finance and Administration | ||
| Craig Tyle, Vice President Assistant Secretary | ||
| Larry Thompson, Independent Trustee | ||
| Steven Gray, Vice President Assistant Secretary | ||
| Aliya Gordon, Vice President Assistant Secretary | ||
| Navid Tofigh, Vice President Assistant Secretary | ||
| Robert Rosselot, Chief Compliance Officer, VP and Secretary | ||
| Gregory Johnson, Trustee | ||
| Lori Weber, Vice President, Secretary | ||
| Constantine Tseretopoulos, Independent Trustee | ||
| Edith Holiday, Lead Independent Trustee | ||
| Harris Ashton, Independent Trustee | ||
| Christine Zhu, Vice President | ||
| Rupert Johnson, Chairman of the Board of Trustee, Vice President | ||
| Breda Beckerle, Interim Chief Compliance Officer | ||
| J Luttig, Independent Trustee | ||
| Michael Hasenstab, President, Chief Executive Officer - Investment Management | ||
| Kimberly Novotny, Vice President Assistant Secretary | ||
| Robert Wade, Independent Trustee | ||
| Mary Choksi, Independent Trustee | ||
| Alison Baur, Vice President Assistant Secretary | ||
| Ann Bates, Independent Trustee |
Templeton Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Templeton Emerging a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -25.3 | ||||
| Return On Asset | 4.18 | ||||
| Profit Margin | (292.75) % | ||||
| Operating Margin | 85.02 % | ||||
| Current Valuation | 251 M | ||||
| Shares Outstanding | 48 M | ||||
| Shares Owned By Institutions | 38.32 % | ||||
| Number Of Shares Shorted | 21.85 K | ||||
| Price To Earning | 61.97 X | ||||
| Price To Book | 0.56 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Templeton Fund
Templeton Emerging financial ratios help investors to determine whether Templeton Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Templeton with respect to the benefits of owning Templeton Emerging security.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |